Ebook COPD - Heterogeneity and personalized treatment: Part 1
➤ Gửi thông báo lỗi ⚠️ Báo cáo tài liệu vi phạmNội dung chi tiết: Ebook COPD - Heterogeneity and personalized treatment: Part 1
Ebook COPD - Heterogeneity and personalized treatment: Part 1
Sang-Do Lee EditorCOPDHeterogeneity and Personalized TreatmentSpringerSang-Do Lee EditorCOPDHeterogeneity and Personalized TreatmentSpringerEditorSang Ebook COPD - Heterogeneity and personalized treatment: Part 1g-Do LeeDepartment of Pulmonary and Critical Care MedicineAsan Medical Center University of Ulsan College of Medicine SeoulSouth KoreaISBN 978-3-662-47177-7ISBN 978-3-662-47178-4 (eBook)DOI IO.1OO7/978-3-662-47178-4Library of Congress Control Number: 2017947875© Springer-Vertag Berlin Heidelberg 201 Ebook COPD - Heterogeneity and personalized treatment: Part 17This work is subject to copyright. All rights are reserved by the Publisher. whether the whole or part of the material is concerned, specifically theEbook COPD - Heterogeneity and personalized treatment: Part 1
rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way. and traSang-Do Lee EditorCOPDHeterogeneity and Personalized TreatmentSpringerSang-Do Lee EditorCOPDHeterogeneity and Personalized TreatmentSpringerEditorSang Ebook COPD - Heterogeneity and personalized treatment: Part 1er developed.The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names arc exempt from the relevant protective laws and regulations and therefore free for general use.The pu Ebook COPD - Heterogeneity and personalized treatment: Part 1blisher, the authors and the editors arc safe to assume that the advice and information in this book are believed to be true and accurate at the dateEbook COPD - Heterogeneity and personalized treatment: Part 1
of publication. Neither the publisher nor the authors Of the editors give a warranty, express or implied, with respect to the material contained hereiSang-Do Lee EditorCOPDHeterogeneity and Personalized TreatmentSpringerSang-Do Lee EditorCOPDHeterogeneity and Personalized TreatmentSpringerEditorSang Ebook COPD - Heterogeneity and personalized treatment: Part 1titutional affiliations.Printed on acid-free paperThis Springer imprint is published by Springer NatureThe registered company is Springer-Vcrlag GmbH GermanyThe registered company address is: Heidclbcrger Platz 3. 14197 Berlin. GermanyPrefaceChronic obstructive pulmonary- disease (COPD) is a leading Ebook COPD - Heterogeneity and personalized treatment: Part 1 cause of morbidity and mortality worldwide. Over the last few decades, the study of COPD has become one of the most rapidly developing fields in mediEbook COPD - Heterogeneity and personalized treatment: Part 1
cine. The recent years have provided clinicians and researchers with major advances in the understanding of underlying mechanisms in COPE). In the pasSang-Do Lee EditorCOPDHeterogeneity and Personalized TreatmentSpringerSang-Do Lee EditorCOPDHeterogeneity and Personalized TreatmentSpringerEditorSang Ebook COPD - Heterogeneity and personalized treatment: Part 1ltiple etiological factors, clinical phenotypes, and comorbidities. One of the main reasons for poor understanding anil poor treatment is the heterogeneity of COPD. The strategy for the management of COPD is moving toward a more personalized approach compared with the historical approach. Dissecting Ebook COPD - Heterogeneity and personalized treatment: Part 1 the heterogeneity would lead to a better understanding and effective personalized treatment of COPD.Airway Vista, also known as Chronic Obstructive AEbook COPD - Heterogeneity and personalized treatment: Part 1
irway Diseases Symposium, has been hosted by the Obstructive Lung Disease Research Foundation in South Korea since 2008. This academic event is designSang-Do Lee EditorCOPDHeterogeneity and Personalized TreatmentSpringerSang-Do Lee EditorCOPDHeterogeneity and Personalized TreatmentSpringerEditorSang Ebook COPD - Heterogeneity and personalized treatment: Part 1the most significant advances in the researches of chronic airw ay diseases. COPD. asthma, and pulmonary functional imaging. We have held Airway Vista successfully every year, featuring more than 50 world-renowned speakers respectively. This year (2017) has marked the 10th anniversary of Airway Vist Ebook COPD - Heterogeneity and personalized treatment: Part 1a. To celebrate the achievements of this 10-year-old symposium, we decided to publish a textbook by gathering the contents of previous symposium progrEbook COPD - Heterogeneity and personalized treatment: Part 1
ams. We have tried to provide readers w ith an overview of COPD. the current understanding of its pathobiology. and a contemporary approach to diagnosSang-Do Lee EditorCOPDHeterogeneity and Personalized TreatmentSpringerSang-Do Lee EditorCOPDHeterogeneity and Personalized TreatmentSpringerEditorSang Ebook COPD - Heterogeneity and personalized treatment: Part 1ders should be aware of.The first chapter of this book covers overviews of COPD which include the current definition, epidemiology, risk factors, and pathogenesis of COPD. The second chapter is comprised of diagnosis and assessment given to COPD patients. In Chap. 3. COPD heterogeneity was described Ebook COPD - Heterogeneity and personalized treatment: Part 1 in a clinical phenotype as well as radiological and genetic aspects. Various pharmacological and nonpharmacological management strategies are revieweEbook COPD - Heterogeneity and personalized treatment: Part 1
d based on evidence in the fourth chapter. The final chapter outlines a future perspective on COPD.This book presents state-of-the-art know ledge on iSang-Do Lee EditorCOPDHeterogeneity and Personalized TreatmentSpringerSang-Do Lee EditorCOPDHeterogeneity and Personalized TreatmentSpringerEditorSang Ebook COPD - Heterogeneity and personalized treatment: Part 1eity (CT/MRI/Scan. BiomarkersVviPrefaceetc.), and tailored treatment strategies in each subgroup of patients. Especially, radiologic imaging is a new promising tool for this issue and will be presented in detail with numerous figures. A further key feature is presentation about the current and futur Ebook COPD - Heterogeneity and personalized treatment: Part 1e treatment strategies for tailored medicine including bronchoscopic lung volume reduction, pulmonary hypertension, and comorbidity management. This tEbook COPD - Heterogeneity and personalized treatment: Part 1
extbook will become a great asset in clinical practice and research to all who are involved or interested in COPE).I would like to acknow ledge the w Sang-Do Lee EditorCOPDHeterogeneity and Personalized TreatmentSpringerSang-Do Lee EditorCOPDHeterogeneity and Personalized TreatmentSpringerEditorSang Ebook COPD - Heterogeneity and personalized treatment: Part 1grateful to all contributing authors from abroad: Norbert Voelkel. Edwin Silverman. Meilan Han. Paul Jones. Rubin Tuder. and Nurdan Kokturk. Finally we wish to thank our families for their patience and consistent support during our academic lives. Ebook COPD - Heterogeneity and personalized treatment: Part 1Sang-Do Lee EditorCOPDHeterogeneity and Personalized TreatmentSpringerSang-Do Lee EditorCOPDHeterogeneity and Personalized TreatmentSpringerEditorSangGọi ngay
Chat zalo
Facebook